an international team of researchers, leveraging synthetic biology and computational protein design tools, have developed a long-sought naturally derived cyan blue colourant sourced from red cabbage anthocyanin pigments that may offer an alternative to the synthetically-produced industry standard blue dye, although more testing is needed to determine the compound’s safety.
The continuous replacement of enzymes and other proteins appropriates up to half the maintenance energy budget in microorganisms and plants. High enzyme replacement rates, therefore, cut the productivity of biosystems ranging from microbial fermentation to crops. Enzyme engineering via synthetic biology to extend its life is proposed by researchers from the University of Florida, Argonne National Laboratory, The University of Chicago and the University of Western, whereby they also present a new benchmark for evaluating the durability of any enzyme.
Agricultural biotechnology strategies often require the precise regulation of multiple genes to effectively modify complex plant traits. However, most efforts are hindered by a lack of characterized tools that allow for reliable and targeted expression of transgenes. Now, researchers at Joint BioEnergy Institute (JBEI) in the USA have developed a new set of synthetic biology tools that could unlock advanced plant engineering.
Plants can be genetically rewired to resist the devastating effects of disease – significantly reducing crop waste worldwide – according to new research into synthetic biology.
Researchers engineer artificial cells that harnesses photosynthesis to perform designer reactions [Registered]
In the quest to build an artificial cell, there are two approaches: The first, re-engineer the genomic software of a living cell. The second, focuses on cellular hardware, building simple, cell-like structures from the ground up that mimic the function of living cells. One of the biggest challenges in this second approach is mimicking the intricate chemical and biological reactions required for cells to perform complex behaviours.
The biotech start-up SimPath has licensed a novel cloning system developed by the Department of Energy’s Oak Ridge National Laboratory (ORNL) that generates and assembles the biological building blocks necessary to synthetically bioengineer new medicines and fuels.
After biofuels and carotenoids, the French biotech start-up Deinove is now moving forward on the cosmetics front. Its engineered microbes can produce a number of high-value chemicals for skin care, and Deinove plans to bring them to market until the end of 2018.